BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 83 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,623 | -51.3% | 18,033 | +28.1% | 0.00% | – |
| Q2 2023 | $93,720 | +15114.3% | 14,072 | +42542.4% | 0.00% | – |
| Q1 2023 | $616 | -13.1% | 33 | 0.0% | 0.00% | – |
| Q4 2022 | $709 | -85.8% | 33 | -92.0% | 0.00% | – |
| Q3 2022 | $5,000 | -37.5% | 415 | -32.1% | 0.00% | – |
| Q2 2022 | $8,000 | -46.7% | 611 | -14.8% | 0.00% | – |
| Q1 2022 | $15,000 | -11.8% | 717 | -13.3% | 0.00% | – |
| Q4 2021 | $17,000 | -46.9% | 827 | -21.2% | 0.00% | – |
| Q3 2021 | $32,000 | -22.0% | 1,050 | -24.9% | 0.00% | – |
| Q2 2021 | $41,000 | -80.7% | 1,398 | -71.6% | 0.00% | – |
| Q1 2021 | $212,000 | -10.9% | 4,916 | -4.7% | 0.00% | -100.0% |
| Q4 2020 | $238,000 | +15.0% | 5,161 | +7.8% | 0.00% | 0.0% |
| Q3 2020 | $207,000 | +66.9% | 4,789 | +105.0% | 0.00% | – |
| Q2 2020 | $124,000 | +82.4% | 2,336 | -22.9% | 0.00% | – |
| Q1 2020 | $68,000 | – | 3,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |